MGH investigators use new drug to save the life of patient with immune thrombotic thrombocytopenic purpura

FHS
May 17, 2024
7:43 pm

A team led by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting throughout the small blood vessels.

How Are Americans Using Emerging Cannabinoids?

About a quarter of Americans have used emerging cannabinoids — such as cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN) — in the past year, according

December 14, 2023

Study assesses the value of predictive biomarkers for early-stage COVID-19 infection

Researchers illustrated that certain biomarkers may be better predictors of COVID-19 than others.

August 2, 2023

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation – Biotech Investments

EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.